secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001193125-24-005933
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron receives Nasdaq deficiency notice for missing annual meeting; appoints Marcum as auditor
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 4, 2024 for failing to hold annual meeting within 12 months after FY2022 end.
- Must submit compliance plan by Feb 20, 2024; Nasdaq may grant extension to June 28, 2024.
- Appointed Marcum LLP as independent auditor for FY2023, effective Jan 9, 2024.
- No prior consultations with Marcum or disagreements with prior auditor reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524005933/0001193125-24-005933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524005933/d78429d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-005933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer